Sanara MedTech (SMTI) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Sanara MedTech (SMTI) over the last 12 years, with Q3 2025 value amounting to $7.33.
- Sanara MedTech's Debt to Equity rose 86995.9% to $7.33 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.33, marking a year-over-year increase of 86995.9%. This contributed to the annual value of $0.78 for FY2024, which is 25825.29% up from last year.
- According to the latest figures from Q3 2025, Sanara MedTech's Debt to Equity is $7.33, which was up 86995.9% from $1.25 recorded in Q2 2025.
- In the past 5 years, Sanara MedTech's Debt to Equity ranged from a high of $7.33 in Q3 2025 and a low of $0.22 during Q4 2023
- Over the past 3 years, Sanara MedTech's median Debt to Equity value was $0.76 (recorded in 2024), while the average stood at $1.37.
- Its Debt to Equity has fluctuated over the past 5 years, first surged by 24403.19% in 2024, then soared by 86995.9% in 2025.
- Sanara MedTech's Debt to Equity (Quarter) stood at $0.22 in 2023, then surged by 258.25% to $0.78 in 2024, then skyrocketed by 841.51% to $7.33 in 2025.
- Its Debt to Equity was $7.33 in Q3 2025, compared to $1.25 in Q2 2025 and $1.18 in Q1 2025.